Protocols
Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus

https://doi.org/10.1016/j.jviromet.2010.11.024Get rights and content

Abstract

The hemagglutination inhibition (HI) assay has been the main method used to investigate immune responses to vaccination against influenza H1N1 (2009) virus. However microneutralization tests (MNT) have been shown to be more sensitive and more specific. In this study, the three methods of choice: (i) the HI assay, (ii) an ELISA-based conventional MNT and (iii) a colorimetric MNT in terms of their ability to detect antibody responses in serum pairs collected from 43 healthy individuals before and 21 days after vaccination were compared. The colorimetric MNT was established yielding intra- and inter-run imprecisions of 7.5% and 12.4%, respectively. Testing of antisera to seasonal influenza viruses demonstrated the assay to be specific for antibodies to influenza H1N1 (2009) virus. A good correlation between the three methods was found, being highest for the ELISA-MNT and the colorimetric MNT (r = 0.714 for geometric mean titers (GMT) and r = 0.695 for titer increases). Similar rates of fourfold titer increases were detected: 95.3% in the ELISA-MNT vs. 93.0% in colorimetric MNT and 95.3% in HI assay. The ELISA-based MNT demonstrated the highest titer range leading to the highest postvaccination GMT and the highest titer increase (>50-fold). The lowest GMTs were measured with the HI assay, while the colormetric MNT detected the highest GMT in prevaccination sera. Taken together, similar seroconversion rates were obtained with the three assays. The ELISA-MNT appeared to be the best method to compare absolute pre- and postvaccination GMTs. The colorimetric MNT, being less labour-intensive than the ELISA-MNT, seems to be a suitable tool in vaccination studies.

Introduction

Clinical trials have investigated immune responses to the monovalent split-virus inactivated vaccine against influenza H1N1 (2009) virus (Liang et al., 2010, Plennevaux et al., 2010, Zhu et al., 2009). In these studies antibody responses were measured mainly by the hemagglutination inhibition (HI) assay because this method can be easily adapted to new influenza viruses. However, it has been shown for seasonal and for avian influenza that microneutralization tests (MNT) are more sensitive and more specific (Frank et al., 1980, Gitelman et al., 1986, Rowe et al., 1999). A previous study for seasonal influenza A indicated that strain-specific IgG antibodies with neutralizing capacity may be present, but these antibodies were not generally detected in homologous HI assays (Remarque et al., 1998). Conventional microneutralization tests are performed in different ways with regard to titer determination, cytopathic effect formation in cell cultures, red blood cells for detection of released virus or usage of the ELISA technique to identify virus infected cells. Especially the ELISA method is time-consuming, difficult to perform under biosafety-level 3 (BSL-3) conditions and requires the need for monoclonal antibodies that are not widely available for new viruses. Recently, a colorimetric MNT has been introduced for seasonal influenza (Lehtoranta et al., 2009). This assay is an adaptation of micro-cytotoxicity tests (van de Water et al., 1993) and is based on the cleavage of a tetrazolium salt by mitochondrial dehydrogenases reflecting the amount of viable and metabolically active cells.

In the present study, the three assays of choice: (i) HI assay, (ii) ELISA-MNT and (iii) colorimetric MNT were compared to detect immune responses in serum pairs collected from 43 healthy individuals before and 21 days after administration of a monovalent vaccine against pandemic influenza H1N1 (2009) virus. The colorimetric MNT was adapted and validated to detect antibodies to pandemic influenza and the method was modified to include less hands-on manipulations.

Section snippets

Cells

MDCK cells (obtained from BioWhittaker Europe, Verviers, Belgium) were grown in Dulbecco's modified essential medium (DMEM) supplemented with penicillin and streptomycin (500 U/ml each) and 2% fetal calf serum and were maintained in a 5% CO2 humified atmosphere at 37 °C. Two to three times a week cells were subcultured at a split-ratio of 1:2–1:5.

Viruses

For the HI assay and the ELISA-MNT the pandemic influenza virus reference strain A/California/7/2009 H1N1 was used. The colorimetric MNT was performed

Validation of the colorimetric microneutralization assay

Specificity was tested with sheep antisera to the purified hemagglutinin of the viruses included in the trivalent split-virus vaccine of the influenza season 2009/2010 (anti-A/Brisbane/59/2007 (H1N1), anti-A/Brisbane/10/2007 (H3N2) and anti-B/Brisbane/60/2008, obtained from NIBSC, London, England). The assay appeared to be specific for antibodies to influenza H1N1 (2009) virus, yielding negative results for all three antisera. A dose response curve of sheep antiserum to the hemagglutinin of the

Discussion

The intention of this study was to compare the GMTs and the titer increases of healthy individuals after vaccination against pandemic influenza H1N1 (2009) virus measured by: (i) HI assay, (ii) conventional ELISA-based MNT and (iii) colorimetric MNT. One of the main findings was that comparable results for fourfold titer increases were obtained with the three assays: 95.3% in the ELISA-MNT (95% CI: 88.7–100) vs. 93.0% (95% CI: 85.1–100) in colorimetric MNT and 95.3% (88.7–100) in HI assay.

Acknowledgements

We wish to thank S. Höveler, H. Lehmann and the other medical technicians of our laboratories for their excellent assistance and Prof. Dr. C.R. MacKenzie for the grammatical review of the manuscript.

References (15)

There are more references available in the full text version of this article.

Cited by (51)

  • Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines

    2021, Vaccine
    Citation Excerpt :

    Also ≥ 4-fold increase in MN titers relative to the baseline value has been used as a correlate of protection [32]. The MN assays appear to have a greater sensitivity [53,55–56] than the HI assay, particularly in serum specimens that show low anti-viral antibody levels [57]. Although MN assays have displayed more intra- and interlaboratory variability than the HI assay [57], a good correlation has been shown between the results of different MN assays [58].

  • Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses

    2019, Vaccine
    Citation Excerpt :

    Measurable anti-influenza antibodies detected by the HI test have been shown to correlate well with protective immunity [6]. In general, HI and MN antibody titres correlate [7], although the MN assays appear to have a greater sensitivity [8–10]. Good correlation has been shown between the results of different MN assays [11], yet the ELISA-based neutralization assays tend to show lower variation [12].

View all citing articles on Scopus
1

These authors contributed equally to this work.

View full text